Datum Källa Rubrik Typ Alternativ
2023-01-26 Iconovo Iconovo erhåller nytt europeiskt patent för sin engångsinhalator ICOone Analyser Ladda ner | Visa Stäng
2023-01-26 Iconovo Iconovo receives approval of new European patent for its single-use inhaler ICOone® Analyser Ladda ner | Visa Stäng
2023-01-17 Iconovo BioStock: Iconovo inleder 2023 med förhandlingar för ICOpre Pressreleaser Visa Stäng
2023-01-17 Iconovo BioStock: Iconovo starts 2023 with negotiations for ICOpre Pressreleaser Visa Stäng
2023-01-11 Iconovo Iconovo har inlett förhandlingar med ett globalt läkemedelsföretag om ett potentiellt licensavtal för sin inhalator ICOpre® Analyser Ladda ner | Visa Stäng
2022-12-15 Iconovo Iconovo utser Henrik Damkjær Simonsen till Chief Financial Officer Analyser Ladda ner | Visa Stäng
2022-12-15 Iconovo Iconovo appoints Henrik Damkjær Simonsen as Chief Financial Officer Analyser Ladda ner | Visa Stäng
2022-12-07 Iconovo Iconovo's ICOone® inhaler platform receives new patent approval in the US Analyser Ladda ner | Visa Stäng
2022-12-07 Iconovo Iconovos inhalatorplattform ICOone® erhåller nytt patentgodkännande i USA Analyser Ladda ner | Visa Stäng
2022-12-05 Iconovo BioStock: Iconovo satsar på läkemedelsförsäljning i Norden Pressreleaser Visa Stäng
2022-12-05 Iconovo BioStock: Iconovo establishes Nordic pharmaceutical sales Pressreleaser Visa Stäng
2022-11-16 Iconovo Iconovo utser Peter Åkerlund till tillförordnad CFO Analyser Ladda ner | Visa Stäng
2022-11-08 Iconovo Valberedning utsedd Iconovo Analyser Ladda ner | Visa Stäng
2022-11-08 Iconovo Nomination Committee appointed at Iconovo Analyser Ladda ner | Visa Stäng
Analyser | 8 Nov 2022 | Iconovo

Nomination Committee appointed at Iconovo

At the Annual General Meeting of 17 May 2022, it was resolved that Iconovo shall have a Nomination Committee consisting of four members representing the four largest shareholders as of 30 September each year.

  The Nomination Committee for the 2022 Annual General Meetings consists of:

Mats Johansson, appointed by Mats Johansson and holding company, and Chairman of the Nomination Committee

Orest Lastow, appointed by Lastow Consulting AB;

Stefan Berger, appointed by Eiffel Investment Group;

Sussi Kvart, appointed by Handelsbanken Fonder

Participates as co-opted;

Gunnar Gårdemyr, Chairman of the Board

The Nomination Committee’s overarching responsibility for the 2023 Annual General Meeting is to present suitable candidates for the positions of Board Chair, Board members and auditor(s) of the Company, and to propose their remuneration.

The Nomination Committee shall prepare proposals in the following matters to be submitted to the Annual General Meeting for decision:

proposal for Chair of the AGM,

proposal for the number of AGM-elected Board members and, where applicable, number of auditors,

proposal for remuneration to non-employed members of the Board and to non-employed members of the various committees of the Board,

proposal for remuneration to the auditors,

proposals for election of Board Chair, other members of the Board and, where applicable, auditors,

proposals for guidelines for appointing members to the Nomination Committee and for the Nomination Committee’s assignments.

 

Shareholders who wish to submit proposals to the Nomination Committee can contact the Nomination Committee by email at gunnar.gardemyr@gmail.com .

In order for the Nomination Committee to process received proposals with sufficient care, these should be received by the Nomination Committee by 1 March 2023.

For more information, please contact:

Gunnar Gårdemyr, Chairman of the Board, gunnar.gardemyr@gmail.com .

2022-11-08 Iconovo BioStock: Iconovo reports Q3 and arranges pandemic event Pressreleaser Visa Stäng
2022-11-08 Iconovo BioStock: Iconovo rapporterar Q3 och arrangerar pandemievent Pressreleaser Visa Stäng
2022-11-04 Penser Access Penser Access: Intervju med Iconovo - Erik Penser Bank - 3 nov 2022 Analyser Visa Stäng
2022-11-03 Iconovo Abbreviated interim report 1 January - 30 September Analyser Ladda ner | Visa Stäng
2022-10-31 Penser Access Penser Access: Leverans av nya avtal på väg - Iconovo Analyser Visa Stäng
2022-10-28 Iconovo DELÅRSRAPPORT 1 JANUARI – 30 SEPTEMBER 2022 Analyser Ladda ner | Visa Stäng
2022-10-24 Iconovo BioStock: Founder and CTO on Iconovo's journey Pressreleaser Visa Stäng
2022-10-24 Iconovo BioStock: Iconovos grundare och CTO om bolagets resa Pressreleaser Visa Stäng
2022-10-24 Iconovo Iconovo's unique single dose inhaler ICOone® Nasal received high marks in user study Analyser Ladda ner | Visa Stäng
2022-10-24 Iconovo Iconovos unika engångsinhalator ICOone® Nasal erhöll goda omdömen i användarstudie Analyser Ladda ner | Visa Stäng
2022-08-12 Iconovo Iconovos Chief Financial Officer kommer att lämna bolaget under fjärde kvartalet 2022 Analyser Ladda ner | Visa Stäng
2022-08-12 Iconovo BioStock: Iconovos vd om anslaget från Bill & Melinda Gates Foundation Pressreleaser Visa Stäng
2022-07-26 Iconovo Iconovo får 9 MSEK i anslag från ansedd internationell stiftelse för att utveckla inhalerade terapier baserade på ICOone Nasal inför nästa pandemi Analyser Ladda ner | Visa Stäng
2022-07-26 Iconovo Iconovo receives USD 883,800 grant from recognized international foundation to develop inhaled therapy with ICOone Nasal for the next pandemic Analyser Ladda ner | Visa Stäng
2022-07-18 Iconovo Abbreviated interim report 1 January - 30 June 2022 Analyser Ladda ner | Visa Stäng
2022-07-15 Penser Access Penser Access: Q2-rapport andas optimism - Iconovo Analyser Visa Stäng
2022-07-15 Iconovo Delårsrapport 1 januari - 30 juni 2022 Analyser Ladda ner | Visa Stäng
2022-06-20 Iconovo BioStock: Iconovo höjer ribban i sina finansiella mål Pressreleaser Visa Stäng
2022-06-16 Penser Access Penser Access: Dags för djup inandning - Iconovo Analyser Visa Stäng
2022-06-13 Iconovo Iconovo receives approval of additional patent for ICOres® in the EU Analyser Ladda ner | Visa Stäng
2022-06-13 Iconovo Iconovo får ytterligare patent godkänt för ICOres® i EU Analyser Ladda ner | Visa Stäng
2022-06-07 Iconovo First patent granted in Japan for Iconovo’s ICOone Analyser Ladda ner | Visa Stäng
2022-06-07 Iconovo Iconovo erhåller förhandsgodkännande av sitt första patent för ICOone® i Japan Analyser Ladda ner | Visa Stäng
2022-06-03 Iconovo Iconovo updates its long-term financial targets – expects strong revenue growth with a high margin Analyser Ladda ner | Visa Stäng
2022-06-01 Iconovo Iconovo uppdaterar sina långsiktiga finansiella mål – ser stark intäktsökning med hög marginal Analyser Ladda ner | Visa Stäng
2022-05-23 Iconovo Iconovos samarbetspartner ISR tecknar avtal med Gerresheimer för storskalig produktion av ICOone Nasal Analyser Ladda ner | Visa Stäng
2022-05-17 Iconovo Kommuniké från årsstämma i Iconovo AB (publ) Analyser Ladda ner | Visa Stäng
2022-05-05 Iconovo BioStock: Iconovo nätverkar på RDD i Orlando Pressreleaser Visa Stäng
2022-05-02 Iconovo Abbreviated interim report 1 January - 31 March 2022 Analyser Ladda ner | Visa Stäng
2022-05-02 Iconovo Iconovo inleder ett strategiskt samarbete med Galenica för utveckling av nya inhalationsläkemedel Analyser Ladda ner | Visa Stäng
2022-05-02 Iconovo Iconovo and Galenica enters a strategic collaboration for the development of new inhalation products Analyser Ladda ner | Visa Stäng
2022-04-29 Iconovo Delårsrapport 1 januari - 31 mars 2022 Analyser Ladda ner | Visa Stäng
2022-04-19 Iconovo ICONOVO AB PUBLICERAR ÅRSREDOVISNING FÖR 2021 Analyser Ladda ner | Visa Stäng
2022-04-12 Iconovo Kallelse till årsstämma i Iconovo AB Analyser Ladda ner | Visa Stäng
2022-04-01 Iconovo BioStock: Iconovo ser ökat intresse inom inhalationsområdet Pressreleaser Visa Stäng
2022-03-29 Iconovo Iconovo extends collaboration with ISR with an agreement worth 13.6 million Swedish kronor (SEK) Analyser Ladda ner | Visa Stäng

Kommande händelser

17 Feb 2023 | Bokslutskommuniké 2022
28 Apr 2023 | Kvartalsrapport 2023-Q1
22 May 2023 | Årsstämma 2022